Copy to clipboard 
nanoMAG executed a license agreement with a strategic partner for the commercial development of its BioMg 250™ bioabsorbable magnesium alloy. The collaboration with the strategic partner is focused on achieving certain milestones, including regulatory approval for this new class of materials for use in orthopaedic applications. nanoMAG LLC, a subsidiary of Thixomat Technologies LLC, made the announcement from their new manufacturing facility in Livonia, Mich.
The nanoMAG strategy is to partner with industry leading biomedical implant makers to design and develop metallic implants to be bioabsorbable, according to LeBeau. These implants are developed using proprietary alloys of magnesium and other compatible elements which provide the appropriate strength and bone support while healing occurs, after which the implant dissolves and is absorbed by the body. The manufacturing process is a miniature version of the larger industrial molding machines that over 50 Thixomat licensees use today to produce millions of consumer parts per year.
According to nanoMAG, magnesium alloy implants are designed to be strong and dissolve over months as the bone recovers its original strength. The density and strength of the nanoMAG magnesium material resembles human bone more than other currently popular implant materials such as plastics or competitive metals. nanoMAG partners have suggested applications such as screws, staples, tacks, wire, rods, plates, and 3D shapes for ligament fixations, craniofacial implants, and small bone implants. “These new magnesium parts could radically change how orthopaedic implants are made and used,” said LeBeau.
Source: nanoMAG
